N-[6-(dimethylamino)-2-(4-hydroxycyclohexyl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[6-(dimethylamino)-2-(4-methylcyclohexyl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-(4,4-dimethylcyclohexyl)-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-(4-hydroxycyclohexyl)-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-(4-hydroxy-4-methylcyclohexyl)-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[6-methoxy-2-(4-methylcyclohexyl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide

C133H142F18N26O13 — CID 164970398

IUPACN-[6-(dimethylamino)-2-(4-hydroxycyclohexyl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[6-(dimethylamino)-2-(4-methylcyclohexyl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-(4,4-dimethylcyclohexyl)-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-(4-hydroxycyclohexyl)-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-(4-hydroxy-4-methylcyclohexyl)-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[6-methoxy-2-(4-methylcyclohexyl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide
SMILESCC1CCC(n2cc3cc(NC(=O)c4cccc(C(F)(F)F)n4)c(N(C)C)cc3n2)CC1.CN(C)c1cc2nn(C3CCC(O)CC3)cc2cc1NC(=O)c1cccc(C(F)(F)F)n1.COc1cc2nn(C3CCC(C)(C)CC3)cc2cc1NC(=O)c1cccc(C(F)(F)F)n1.COc1cc2nn(C3CCC(C)(O)CC3)cc2cc1NC(=O)c1cccc(C(F)(F)F)n1.COc1cc2nn(C3CCC(C)CC3)cc2cc1NC(=O)c1cccc(C(F)(F)F)n1.COc1cc2nn(C3CCC(O)CC3)cc2cc1NC(=O)c1cccc(C(F)(F)F)n1
InChIInChI=1S/C23H26F3N5O.C23H25F3N4O2.C22H24F3N5O2.C22H23F3N4O3.C22H23F3N4O2.C21H21F3N4O3/c1-14-7-9-16(10-8-14)31-13-15-11-19(20(30(2)3)12-18(15)29-31)28-22(32)17-5-4-6-21(27-17)23(24,25)26;1-22(2)9-7-15(8-10-22)30-13-14-11-18(19(32-3)12-17(14)29-30)28-21(31)16-5-4-6-20(27-16)23(24,25)26;1-29(2)19-11-17-13(12-30(28-17)14-6-8-15(31)9-7-14)10-18(19)27-21(32)16-4-3-5-20(26-16)22(23,24)25;1-21(31)8-6-14(7-9-21)29-12-13-10-17(18(32-2)11-16(13)28-29)27-20(30)15-4-3-5-19(26-15)22(23,24)25;1-13-6-8-15(9-7-13)29-12-14-10-18(19(31-2)11-17(14)28-29)27-21(30)16-4-3-5-20(26-16)22(23,24)25;1-31-18-10-16-12(11-28(27-16)13-5-7-14(29)8-6-13)9-17(18)26-20(30)15-3-2-4-19(25-15)21(22,23)24/h4-6,11-14,16H,7-10H2,1-3H3,(H,28,32);4-6,11-13,15H,7-10H2,1-3H3,(H,28,31);3-5,10-12,14-15,31H,6-9H2,1-2H3,(H,27,32);3-5,10-12,14,31H,6-9H2,1-2H3,(H,27,30);3-5,10-13,15H,6-9H2,1-2H3,(H,27,30);2-4,9-11,13-14,29H,5-8H2,1H3,(H,26,30)
InChIKeyDAUGBLKWVKDVKC-UHFFFAOYSA-N
MW2654.73 g/mol
LogP29.84
Rot. Bonds24

About N-[6-(dimethylamino)-2-(4-hydroxycyclohexyl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[6-(dimethylamino)-2-(4-methylcyclohexyl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-(4,4-dimethylcyclohexyl)-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-(4-hydroxycyclohexyl)-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-(4-hydroxy-4-methylcyclohexyl)-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[6-methoxy-2-(4-methylcyclohexyl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide

N-[6-(dimethylamino)-2-(4-hydroxycyclohexyl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[6-(dimethylamino)-2-(4-methylcyclohexyl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-(4,4-dimethylcyclohexyl)-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-(4-hydroxycyclohexyl)-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-(4-hydroxy-4-methylcyclohexyl)-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[6-methoxy-2-(4-methylcyclohexyl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide (PubChem CID 164970398) has the molecular formula C133H142F18N26O13 and a molecular weight of 2654.73 g/mol. Its IUPAC name is N-[6-(dimethylamino)-2-(4-hydroxycyclohexyl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[6-(dimethylamino)-2-(4-methylcyclohexyl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-(4,4-dimethylcyclohexyl)-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-(4-hydroxycyclohexyl)-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-(4-hydroxy-4-methylcyclohexyl)-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[6-methoxy-2-(4-methylcyclohexyl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide.

Molecular Properties

Compound NameN-[6-(dimethylamino)-2-(4-hydroxycyclohexyl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[6-(dimethylamino)-2-(4-methylcyclohexyl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-(4,4-dimethylcyclohexyl)-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-(4-hydroxycyclohexyl)-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-(4-hydroxy-4-methylcyclohexyl)-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[6-methoxy-2-(4-methylcyclohexyl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide
PubChem CID164970398
Molecular FormulaC133H142F18N26O13
Molecular Weight2654.73 g/mol
Exact Mass2653.10
IUPAC NameN-[6-(dimethylamino)-2-(4-hydroxycyclohexyl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[6-(dimethylamino)-2-(4-methylcyclohexyl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-(4,4-dimethylcyclohexyl)-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-(4-hydroxycyclohexyl)-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-(4-hydroxy-4-methylcyclohexyl)-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[6-methoxy-2-(4-methylcyclohexyl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide
SMILESCC1CCC(n2cc3cc(NC(=O)c4cccc(C(F)(F)F)n4)c(N(C)C)cc3n2)CC1.CN(C)c1cc2nn(C3CCC(O)CC3)cc2cc1NC(=O)c1cccc(C(F)(F)F)n1.COc1cc2nn(C3CCC(C)(C)CC3)cc2cc1NC(=O)c1cccc(C(F)(F)F)n1.COc1cc2nn(C3CCC(C)(O)CC3)cc2cc1NC(=O)c1cccc(C(F)(F)F)n1.COc1cc2nn(C3CCC(C)CC3)cc2cc1NC(=O)c1cccc(C(F)(F)F)n1.COc1cc2nn(C3CCC(O)CC3)cc2cc1NC(=O)c1cccc(C(F)(F)F)n1
InChIInChI=1S/C23H26F3N5O.C23H25F3N4O2.C22H24F3N5O2.C22H23F3N4O3.C22H23F3N4O2.C21H21F3N4O3/c1-14-7-9-16(10-8-14)31-13-15-11-19(20(30(2)3)12-18(15)29-31)28-22(32)17-5-4-6-21(27-17)23(24,25)26;1-22(2)9-7-15(8-10-22)30-13-14-11-18(19(32-3)12-17(14)29-30)28-21(31)16-5-4-6-20(27-16)23(24,25)26;1-29(2)19-11-17-13(12-30(28-17)14-6-8-15(31)9-7-14)10-18(19)27-21(32)16-4-3-5-20(26-16)22(23,24)25;1-21(31)8-6-14(7-9-21)29-12-13-10-17(18(32-2)11-16(13)28-29)27-20(30)15-4-3-5-19(26-15)22(23,24)25;1-13-6-8-15(9-7-13)29-12-14-10-18(19(31-2)11-17(14)28-29)27-21(30)16-4-3-5-20(26-16)22(23,24)25;1-31-18-10-16-12(11-28(27-16)13-5-7-14(29)8-6-13)9-17(18)26-20(30)15-3-2-4-19(25-15)21(22,23)24/h4-6,11-14,16H,7-10H2,1-3H3,(H,28,32);4-6,11-13,15H,7-10H2,1-3H3,(H,28,31);3-5,10-12,14-15,31H,6-9H2,1-2H3,(H,27,32);3-5,10-12,14,31H,6-9H2,1-2H3,(H,27,30);3-5,10-13,15H,6-9H2,1-2H3,(H,27,30);2-4,9-11,13-14,29H,5-8H2,1H3,(H,26,30)
InChIKeyDAUGBLKWVKDVKC-UHFFFAOYSA-N
XLogP29.84
TPSA462.95 Ų
H-Bond Donors9
H-Bond Acceptors33
Rotatable Bonds24
Heavy Atoms190
Complexity—

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002654.73
LogP ≤ 529.84
H-Bond Donors ≤ 59
H-Bond Acceptors ≤ 1033

Analyze N-[6-(dimethylamino)-2-(4-hydroxycyclohexyl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[6-(dimethylamino)-2-(4-methylcyclohexyl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-(4,4-dimethylcyclohexyl)-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-(4-hydroxycyclohexyl)-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-(4-hydroxy-4-methylcyclohexyl)-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[6-methoxy-2-(4-methylcyclohexyl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

US20240423977, Example I-27
CID 175664373
US20240423977, Example I-32
CID 175664378
US20240423977, Example I-33
CID 175664379
N-[2-[4-[[[1-[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-4-yl]piperidin-4-yl]methylamino]methyl]cyclohexyl]-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide
CID 155437841
N-[2-[4-[[[1-[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-4-yl]piperidin-4-yl]-methylamino]methyl]cyclohexyl]-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide
CID 155437844
N-[2-[4-[[[1-[1-[(3R)-2,6-dioxopiperidin-3-yl]-3-methyl-2-oxobenzimidazol-4-yl]piperidin-4-yl]methylamino]methyl]cyclohexyl]-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide
CID 155438101
N-[2-[4-[[[1-[1-[(3R)-2,6-dioxopiperidin-3-yl]-3-methyl-2-oxobenzimidazol-4-yl]piperidin-4-yl]-methylamino]methyl]cyclohexyl]-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide
CID 155438104
N-[2-[4-[[[1-[1-[(3S)-2,6-dioxopiperidin-3-yl]-3-methyl-2-oxobenzimidazol-4-yl]piperidin-4-yl]methylamino]methyl]cyclohexyl]-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide
CID 155438499
N-[2-[4-[[[1-[1-[(3S)-2,6-dioxopiperidin-3-yl]-3-methyl-2-oxobenzimidazol-4-yl]piperidin-4-yl]-methylamino]methyl]cyclohexyl]-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide
CID 155438502
N-[2-[4-[[2-(3-hydroxypropyl)-7-azaspiro[3.5]nonan-7-yl]methyl]cyclohexyl]-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide
CID 155438793
N-[2-[4-[[[2-[[3-[[4-[2-[7-[[4-[6-cyclopropyloxy-5-[[6-(trifluoromethyl)pyridine-2-carbonyl]amino]indazol-2-yl]cyclohexyl]methyl]-7-azaspiro[3.5]nonan-2-yl]ethylamino]-2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-5-yl]methyl]-1-(2,6-dioxopiperidin-3-yl)-2-oxobenzimidazol-4-yl]methyl]spiro[3.5]nonan-7-yl]-methylamino]methyl]cyclohexyl]-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide
CID 155448663
N-[2-[4-[[4-[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-5-yl]piperazin-1-yl]methyl]cyclohexyl]-6-methoxyindazol-5-yl]-6-(2-fluoropropan-2-yl)pyridine-2-carboxamide
CID 155448664

Frequently Asked Questions

What is the IUPAC name of N-[6-(dimethylamino)-2-(4-hydroxycyclohexyl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[6-(dimethylamino)-2-(4-methylcyclohexyl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-(4,4-dimethylcyclohexyl)-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-(4-hydroxycyclohexyl)-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-(4-hydroxy-4-methylcyclohexyl)-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[6-methoxy-2-(4-methylcyclohexyl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide?
The IUPAC name of N-[6-(dimethylamino)-2-(4-hydroxycyclohexyl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[6-(dimethylamino)-2-(4-methylcyclohexyl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-(4,4-dimethylcyclohexyl)-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-(4-hydroxycyclohexyl)-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-(4-hydroxy-4-methylcyclohexyl)-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[6-methoxy-2-(4-methylcyclohexyl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide (CID 164970398) is N-[6-(dimethylamino)-2-(4-hydroxycyclohexyl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[6-(dimethylamino)-2-(4-methylcyclohexyl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-(4,4-dimethylcyclohexyl)-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-(4-hydroxycyclohexyl)-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-(4-hydroxy-4-methylcyclohexyl)-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[6-methoxy-2-(4-methylcyclohexyl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide.
What is the SMILES notation for N-[6-(dimethylamino)-2-(4-hydroxycyclohexyl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[6-(dimethylamino)-2-(4-methylcyclohexyl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-(4,4-dimethylcyclohexyl)-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-(4-hydroxycyclohexyl)-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-(4-hydroxy-4-methylcyclohexyl)-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[6-methoxy-2-(4-methylcyclohexyl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide?
The canonical SMILES for N-[6-(dimethylamino)-2-(4-hydroxycyclohexyl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[6-(dimethylamino)-2-(4-methylcyclohexyl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-(4,4-dimethylcyclohexyl)-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-(4-hydroxycyclohexyl)-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-(4-hydroxy-4-methylcyclohexyl)-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[6-methoxy-2-(4-methylcyclohexyl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide is CC1CCC(n2cc3cc(NC(=O)c4cccc(C(F)(F)F)n4)c(N(C)C)cc3n2)CC1.CN(C)c1cc2nn(C3CCC(O)CC3)cc2cc1NC(=O)c1cccc(C(F)(F)F)n1.COc1cc2nn(C3CCC(C)(C)CC3)cc2cc1NC(=O)c1cccc(C(F)(F)F)n1.COc1cc2nn(C3CCC(C)(O)CC3)cc2cc1NC(=O)c1cccc(C(F)(F)F)n1.COc1cc2nn(C3CCC(C)CC3)cc2cc1NC(=O)c1cccc(C(F)(F)F)n1.COc1cc2nn(C3CCC(O)CC3)cc2cc1NC(=O)c1cccc(C(F)(F)F)n1.
What is the InChIKey of N-[6-(dimethylamino)-2-(4-hydroxycyclohexyl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[6-(dimethylamino)-2-(4-methylcyclohexyl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-(4,4-dimethylcyclohexyl)-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-(4-hydroxycyclohexyl)-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-(4-hydroxy-4-methylcyclohexyl)-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[6-methoxy-2-(4-methylcyclohexyl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide?
The InChIKey is DAUGBLKWVKDVKC-UHFFFAOYSA-N. The full InChI is InChI=1S/C23H26F3N5O.C23H25F3N4O2.C22H24F3N5O2.C22H23F3N4O3.C22H23F3N4O2.C21H21F3N4O3/c1-14-7-9-16(10-8-14)31-13-15-11-19(20(30(2)3)12-18(15)29-31)28-22(32)17-5-4-6-21(27-17)23(24,25)26;1-22(2)9-7-15(8-10-22)30-13-14-11-18(19(32-3)12-17(14)29-30)28-21(31)16-5-4-6-20(27-16)23(24,25)26;1-29(2)19-11-17-13(12-30(28-17)14-6-8-15(31)9-7-14)10-18(19)27-21(32)16-4-3-5-20(26-16)22(23,24)25;1-21(31)8-6-14(7-9-21)29-12-13-10-17(18(32-2)11-16(13)28-29)27-20(30)15-4-3-5-19(26-15)22(23,24)25;1-13-6-8-15(9-7-13)29-12-14-10-18(19(31-2)11-17(14)28-29)27-21(30)16-4-3-5-20(26-16)22(23,24)25;1-31-18-10-16-12(11-28(27-16)13-5-7-14(29)8-6-13)9-17(18)26-20(30)15-3-2-4-19(25-15)21(22,23)24/h4-6,11-14,16H,7-10H2,1-3H3,(H,28,32);4-6,11-13,15H,7-10H2,1-3H3,(H,28,31);3-5,10-12,14-15,31H,6-9H2,1-2H3,(H,27,32);3-5,10-12,14,31H,6-9H2,1-2H3,(H,27,30);3-5,10-13,15H,6-9H2,1-2H3,(H,27,30);2-4,9-11,13-14,29H,5-8H2,1H3,(H,26,30).
What are the key properties of N-[6-(dimethylamino)-2-(4-hydroxycyclohexyl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[6-(dimethylamino)-2-(4-methylcyclohexyl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-(4,4-dimethylcyclohexyl)-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-(4-hydroxycyclohexyl)-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-(4-hydroxy-4-methylcyclohexyl)-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[6-methoxy-2-(4-methylcyclohexyl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide?
N-[6-(dimethylamino)-2-(4-hydroxycyclohexyl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[6-(dimethylamino)-2-(4-methylcyclohexyl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-(4,4-dimethylcyclohexyl)-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-(4-hydroxycyclohexyl)-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-(4-hydroxy-4-methylcyclohexyl)-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[6-methoxy-2-(4-methylcyclohexyl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide has a molecular weight of 2654.73 g/mol, XLogP of 29.84, 24 rotatable bonds, 9 hydrogen bond donors, and 33 hydrogen bond acceptors.
Where does this data come from?
All data for N-[6-(dimethylamino)-2-(4-hydroxycyclohexyl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[6-(dimethylamino)-2-(4-methylcyclohexyl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-(4,4-dimethylcyclohexyl)-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-(4-hydroxycyclohexyl)-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-(4-hydroxy-4-methylcyclohexyl)-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[6-methoxy-2-(4-methylcyclohexyl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide is sourced from PubChem (CID 164970398), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).